{
    "clinical_study": {
        "@rank": "164921", 
        "arm_group": [
            {
                "arm_group_label": "B", 
                "description": "Unresectable or metastatic PDAC patients who will receive standard treatment of CT +/- radiotherapy"
            }, 
            {
                "arm_group_label": "A", 
                "description": "Resectable PDAC patients who will receive standard treatment of CT +/- radiotherapy"
            }
        ], 
        "brief_summary": {
            "textblock": "This is an exploratory, translational, non-interventional and multi-centre clinical study.\n      The aim of the study is to identify predictive plasma biomarkers of response to chemotherapy\n      in PDAC."
        }, 
        "brief_title": "Plasma Biomarkers PDAC, V1", 
        "condition": "Pancreatic Ductal Adenocarcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Carcinoma, Ductal, Breast"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will involve two cohort groups, all patients involved will have PDAC.\n\n      Cohort A will involve resectable PDAC patients who will receive standard treatment of CT\n      (with/without radiotherapy).\n\n      Cohort B will comprise of unresectable advanced PDAC patients and metastatic PDAC patients,\n      both of whom will receive standard treatment of CT (with/without radiotherapy).\n\n      Blood samples will be taken at the following time points:\n\n        -  prior to resection, whenever feasible for cohort A\n\n        -  prior to CT, for both cohort A and B\n\n        -  during CT, for both cohort A and B\n\n        -  follow-up, approximately every 3 to 6 months for two years for cohort A"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years of age\n\n          -  Ability to give written informed consent\n\n          -  Histologically or cytologically-confirmed PDAC\n\n          -  Patients who will receive standard treatment of CT +/- radiotherapy and   present\n             with:\n\n        Cohort A: resectable cancer OR Cohort B.1: unresectable locally advanced cancer OR Cohort\n        B.2: metastatic cancer\n\n          -  Eastern Cooperative Oncology Group (ECOG) Performance status 0 - 2\n\n        Exclusion Criteria:\n\n          -  Presence of medical or psychiatric conditions, which, in the opinion of the\n             investigator, would potentially pose a risk to the patient in participating in this\n             study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients on this study must have pancreatic ductal adenocarcinoma."
            }
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050997", 
            "org_study_id": "ICORG 12-31"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cork", 
                        "country": "Ireland"
                    }, 
                    "name": "Cork University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-8377547"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "Beaumont Hospital"
                }, 
                "investigator": {
                    "last_name": "Liam Grogan, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-2214117"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "St Vincent's Hospital"
                }, 
                "investigator": {
                    "last_name": "Ray McDermott, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galway", 
                        "country": "Ireland"
                    }, 
                    "name": "Galway University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limerick", 
                        "country": "Ireland"
                    }, 
                    "name": "Midwestern Regional Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-4142000"
                }, 
                "facility": {
                    "address": {
                        "city": "Tallaght", 
                        "country": "Ireland", 
                        "zip": "24"
                    }, 
                    "name": "Adelaide Meath National Childrens Hospital"
                }, 
                "investigator": {
                    "last_name": "MinYuen Teo, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "051-848000"
                }, 
                "facility": {
                    "address": {
                        "city": "Waterford", 
                        "country": "Ireland"
                    }, 
                    "name": "Waterford Regional Hospital"
                }, 
                "investigator": {
                    "last_name": "Anne Horgan, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Ireland"
        }, 
        "number_of_groups": "2", 
        "official_title": "Identification of Predictive Plasma Biomarkers in Pancreatic Ductal Adenocarcinoma (PDAC Plasma Biomarker Study)", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Ireland: Health Information and Quality Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Identify plasma biomarkers that are predictive for response to treatment as defined by time to recurrence", 
            "measure": "Time to disease recurrence", 
            "safety_issue": "No", 
            "time_frame": "Blood samples analysed up to 2 year follow up, estimated 4 years in total"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050997"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To discover plasma biomarkers that are predictive for response to treatment as defined by progression free survival", 
                "measure": "Rate of progression free survival", 
                "safety_issue": "No", 
                "time_frame": "Blood samples analysed up to 2 year follow up, estimated 4 years in total"
            }, 
            {
                "description": "Aim to validate a panel of predicitive plasma biomarkers proving its accuracy, sensitivity, specificity and to investigate their expression at tissue level gaining a further understanding of cancer and/or host related proteins in disease response and progression", 
                "measure": "Accuracy, sensitivity, specificity and concordance index", 
                "safety_issue": "No", 
                "time_frame": "For the duration of study, expected 4 years"
            }
        ], 
        "source": "ICORG- All Ireland Cooperative Oncology Research Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ICORG- All Ireland Cooperative Oncology Research Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}